The Ministry of Health revealed Friday that demand for Lenacapavir, an HIV prevention injection launched in April, currently surpasses available doses, with more men demanding the twice-yearly drug.
Speaking at a meeting attended by HIV advocates, researchers and policymakers, Dr Herbert Kadama who coordinates Pre-Exposure Prophylaxis (PrEP) at the Ministry of Health, said more men than women, in a surprising trend, are going to health facilities seeking the drug that’s currently offered to those at very high risk of acquiring HIV.
Even as the drug is not for everyone but those thoroughly screened to meet the criteria, Kadama says they continue receiving many calls from different categories of people asking where and how they can get the drug.